bioAffinity Technologies (BIAFW) Retained Earnings (2021 - 2026)

bioAffinity Technologies has disclosed Retained Earnings across 6 years of filings, most recently posting -$72.2 million for Q1 2026.

• In Q1 2026, Retained Earnings fell 28.23% year-over-year to -$72.2 million; the TTM figure through Mar 2026 stood at -$72.2 million (down 28.23% YoY), while the FY2025 annual figure was -$68.6 million, down 27.79% from the prior year.
• Retained Earnings declined to -$72.2 million in Q1 2026, from -$68.6 million in the prior quarter.
• Over the last five years, Retained Earnings for BIAFW reached as high as -$35.0 million in Q3 2022 and fell as low as -$72.2 million in Q1 2026.
• The 5-year median for Retained Earnings is -$48.7 million (2024), against an average of -$50.6 million.
• Annual changes were most pronounced in 2024 — Retained Earnings retreated 20.05% — and 2025, when it fell 28.99%.
• A 5-year view of Retained Earnings shows it stood at -$36.7 million in 2022, then declined by 21.65% to -$44.6 million in 2023, then slipped by 20.27% to -$53.6 million in 2024, then declined by 27.79% to -$68.6 million in 2025, then retreated by 5.32% to -$72.2 million in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered -$72.2 million, -$68.6 million, and -$65.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.